Is Aster DM Healthcare a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Aster DM Healthcare Ltd is a average quality company .

Is Aster DM Healthcare undervalued or overvalued?

The key valuation ratios of Aster DM Healthcare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Aster DM Healthcare share price return in the past 10 years?

Data is not available for this company

Is Aster DM Healthcare a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Aster DM Healthcare Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

Aster DM Healthcare Ltd - Stock Valuation and Financial Performance

Name: Aster DM Healthcare
Brand: Aster DM Healthcare

BSE: 540975 | NSE: ASTERDM | Hospital & Healthcare Services | Small Cap

Place order

Aster DM Healthcare Share Price

₹426.55 -6.95 -1.60%
as on 21-Nov'24 16:00

10 Year X-Ray of Aster DM Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	15.4%	7.7%	11.5%	10.4%	11%	11.8%	9%	16%	4.5%	5.8%	-
Value Creation Index ⓘ	0.4	-0.3	0.0	-0.2	-0.2	-0.1	-0.3	0.2	-0.7	-0.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	3,876	5,250	5,931	6,721	7,963	8,652	8,608	10,253	2,994	3,699	6,773
Sales YoY Gr.	-	35.5%	13%	13.3%	18.5%	8.7%	-0.5%	19.1%	-70.8%	23.5%	-
Adj EPS ⓘ	3.4	-1.5	-4.7	4.1	6.6	5.9	3.2	10.5	2.2	2.5	108.1
YoY Gr.	-	-142.3%	NA	NA	60.1%	-11.5%	-45.1%	228%	-79.3%	12.4%	-
BVPS (₹) ⓘ	38.2	10.4	46.5	56.1	63.6	65.9	67.9	79.1	81.4	83.6	68.8
Adj Net Profit ⓘ	133	-58.5	-190	209	334	291	159	526	109	122	5,397
Cash Flow from Ops. ⓘ	236	203	361	537	601	1,223	1,569	1,314	1,834	158	-
Debt/CF from Ops. ⓘ	4.6	16.4	7.6	4.4	4.6	2.4	1.5	1.7	1.3	12.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-0.5%	-14.2%	-24.5%	23.5%
Adj EPS ⓘ	-3.7%	-18%	-8.6%	12.4%
BVPSⓘ	9.1%	5.6%	7.2%	2.7%
Share Price	-	24.1%	29.5%	26.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	9	-6.2	-16.5	8.9	11	9	4.8	14.4	2.6	2.7	141.8
Op. Profit Mgn % ⓘ	13.4	8.8	5.9	9.4	11.2	14.9	13	15	15.3	15.9	16.3
Net Profit Mgn % ⓘ	7	0.2	-3.3	3.3	4.6	3.8	2.2	5.9	5.3	5.5	79.7
Debt to Equity ⓘ	0.7	7.9	1.5	0.8	0.9	0.9	0.7	0.6	0.5	0.4	0.1
Working Cap Days ⓘ	0	147	165	158	154	170	168	137	554	504	57
Cash Conv. Cycle ⓘ	0	52	56	54	60	49	28	15	36	-9	14

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 141.80%

Sales growth is good in last 4 quarters at 18.22%

Sales growth has been subdued in last 3 years -24.54%

Net Profit has been subdued in last 3 years -8.61%

Latest Financials - Aster DM Healthcare Ltd.

	Standalone	Consolidated
TTM EPS (₹)	123	108.1
TTM Sales (₹ Cr.)	2,240	6,773
BVPS (₹.) ⓘ	67.5	68.8
Reserves (₹ Cr.) ⓘ	2,871	2,936
P/BV ⓘ	6.42	6.30
PE ⓘ	3.52	4.01

From the Market
52 Week Low / High (₹)	312.25 / 558.30
All Time Low / High (₹)	78.50 / 558.30
Market Cap (₹ Cr.)	21,654
Equity (₹ Cr.)	499.5
Face Value (₹)	10
Industry PE ⓘ	40.2

Management X-Ray of Aster DM Healthcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

10.44

98.87

* Pledged shares as % of Promoter's holding (%)

Valuation of Aster DM Healthcare

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Aster DM Healthcare

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	3,876	5,250	5,931	6,721	7,963	8,652	8,608	10,253	2,994	3,699
Operating Expenses ⓘ	3,358	4,789	5,582	6,089	7,074	7,363	7,506	8,720	2,536	3,112
Manufacturing Costs	385	552	732	849	982	1,162	1,352	1,596	992	1,193
Material Costs	1,222	1,623	1,887	2,059	2,420	2,539	2,549	2,892	779	916
Employee Cost	1,154	1,629	2,055	2,271	2,688	2,904	2,755	3,264	542	676
Other Costs ⓘ	598	985	908	910	984	758	850	968	223	327
Operating Profit ⓘ	518	461	349	632	889	1,289	1,103	1,533	458	587
Operating Profit Margin (%)	13.4%	8.8%	5.9%	9.4%	11.2%	14.9%	12.8%	15.0%	15.3%	15.9%
Other Income ⓘ	23	25	37	45	35	38	50	51	37	25
Interest ⓘ	91	205	371	204	205	391	334	307	96	119
Depreciation ⓘ	144	243	322	298	306	586	618	641	192	220
Exceptional Items ⓘ	0	0	416	130	-2	-20	0	0	0	0
Profit Before Tax ⓘ	306	38	108	308	410	330	205	637	195	261
Tax ⓘ	34	29	11	26	43	15	27	36	36	57
Profit After Tax	272	8	98	282	367	315	178	601	160	205
PAT Margin (%)	7.0%	0.2%	1.6%	4.2%	4.6%	3.6%	2.1%	5.9%	5.3%	5.5%
Adjusted EPS (₹)	3.4	-1.5	2.5	5.3	6.6	5.6	3.0	10.5	8.5	2.6
Dividend Payout Ratio (%)	0%	-3%	0%	0%	0%	0%	0%	0%	0%	77%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	1,484	420	1,875	2,832	3,214	3,272	3,372	3,953	4,442	4,552
Share Capital ⓘ	389	403	403	505	505	497	497	500	874	874
Reserves ⓘ	1,096	17	1,472	2,327	2,709	2,775	2,875	3,454	3,568	3,678
Minority Interest	762	177	375	358	466	446	462	529	412	470
Debt	901	3,162	2,721	2,212	2,608	2,479	1,914	1,757	1,813	1,790
Long Term Debt	612	2,577	1,891	1,578	1,966	1,892	1,755	1,466	1,312	446
Short Term Debt	289	584	830	635	642	587	159	291	500	1,343
Trade Payables	432	697	782	846	1,014	2,110	2,027	2,118	2,988	3,436
Others Liabilities ⓘ	830	1,288	1,050	1,231	1,627	4,097	3,844	4,164	5,181	7,735
Total Liabilities ⓘ	4,409	5,743	6,804	7,479	8,928	12,405	11,620	12,521	14,836	17,983
Fixed Assets
Gross Block	2,650	3,175	4,484	5,000	5,901	9,436	9,430	9,992	12,704	4,903
Accumulated Depreciation	414	667	964	1,262	1,612	2,313	2,681	2,983	3,652	1,728
Net Fixed Assetsⓘ	2,237	2,507	3,520	3,738	4,289	7,124	6,749	7,009	9,052	3,175
CWIP ⓘ	197	358	290	402	550	736	934	998	279	170
Investmentsⓘ	14	50	32	38	22	34	63	45	80	17
Inventories	311	411	526	627	732	961	849	1,026	1,306	1,632
Trade Receivables	884	1,342	1,288	1,546	2,029	2,366	2,019	2,021	2,336	2,440
Cash Equivalents	304	267	152	300	341	177	281	380	429	2,550
Others Assetsⓘ	461	808	997	828	965	1,007	725	1,044	1,354	7,998
Total Assets ⓘ	4,409	5,743	6,804	7,479	8,928	12,405	11,620	12,521	14,836	17,983

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	236	203	361	537	601	1,223	1,569	1,314	1,834	158
PBT ⓘ	306	38	-307	176	412	330	205	637	535	330
Adjustment ⓘ	442	879	871	590	665	1,136	1,179	1,136	1,270	1,570
Changes in Working Capital ⓘ	-490	-681	-159	-176	-422	-177	196	-402	88	-1671
Tax Paid ⓘ	-22	-34	-44	-52	-54	-66	-11	-57	-59	-71
Cash Flow From Investing Activity ⓘ	-448	-786	-1,153	-523	-709	-667	-330	-570	-972	-885
Capex	-411	-745	-926	-520	-537	-430	-386	-544	-839	-759
Net Investments	-30	-48	-68	23	-17	-9	53	-14	-118	-127
Others ⓘ	-7	8	-158	-25	-154	-228	3	-12	-15	2
Cash Flow From Financing Activityⓘ	203	578	654	46	134	-675	-1,116	-686	-817	1,053
Net Proceeds from Shares ⓘ	94	79	8	681	2	1	1	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	163	-365	-299	-244	1,519
Interest Paid ⓘ	-80	-89	-174	-177	-175	-200	-163	-122	-149	-210
Dividend Paid ⓘ	-17	-49	-10	-30	0	-10	-9	-20	-27	-22
Others ⓘ	205	637	831	-428	307	-629	-579	-244	-397	-234
Net Cash Flow ⓘ	-10	-5	-138	61	26	-119	123	58	45	326

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	18.33	0.86	8.5	11.97	12.15	9.7	5.35	16.41	3.98	4.97
ROCE (%)	15.42	7.69	11.45	10.43	11	11.77	9.03	15.96	4.52	5.76
Asset Turnover Ratio	0.88	1.03	0.95	0.94	0.97	0.81	0.72	0.85	0.22	0.23
PAT to CFO Conversion(x)	0.87	25.38	3.68	1.9	1.64	3.88	8.81	2.19	11.46	0.77
Working Capital Days
Receivable Days	83	77	81	77	82	93	93	72	266	236
Inventory Days	29	25	29	31	31	36	38	33	142	145
Payable Days	129	127	143	144	140	225	296	262	1,196	1,280

Aster DM Healthcare Ltd Stock News

Aster DM Healthcare Ltd FAQs

What is the share price of Aster DM Healthcare?

Company share prices are keep on changing according to the market conditions. The closing price of Aster DM Healthcare on 21-Nov-2024 16:00 is ₹426.6.

What is the market cap of Aster DM Healthcare?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:00 the market cap of Aster DM Healthcare stood at ₹21,653.9.

What is the P/E ratio of Aster DM Healthcare?

The latest P/E ratio of Aster DM Healthcare as of 21-Nov-2024 16:00 is 3.52.

What is the P/B ratio of Aster DM Healthcare?

The latest P/B ratio of Aster DM Healthcare as of 21-Nov-2024 16:00 is 6.42.

What is the 52-week high and low of Aster DM Healthcare?

The 52-week high of Aster DM Healthcare is ₹558.3 and the 52-week low is ₹312.2.

What is the TTM revenue of Aster DM Healthcare?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aster DM Healthcare is ₹2,240 ( Cr.) .

About Aster DM Healthcare Ltd

The company was incorporated on January 18, 2008 as ‘DM Healthcare Private Limited’ at Kochi, Ernakulam, Kerala as a private limited company under the Companies Act, 1956. The name of company was changed to ‘Aster DM Healthcare Private Limited’ and a fresh certificate of incorporation consequent upon change of name was issued on November 29, 2013. Subsequently, the company was converted into a public company pursuant to special resolution passed by shareholders on November 10, 2014 and the name of the company was changed to ‘Aster DM Healthcare Limited’ a Fresh Certificate of Incorporation consequent upon conversion to public limited Company dated on January 1, 2015.

The company is one of the largest private healthcare service providers which operate in multiple GCC states based on numbers of hospitals and clinics. It currently operate in all of the GCC states, which comprise the United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait and Bahrain, in Jordan, in India and the Philippines. Its GCC operations are headquartered in Dubai, United Arab Emirates and Indian operations are headquartered in Kochi, Kerala. The company has a diversified portfolio of healthcare facilities, consisting of 9 hospitals, 90 clinics and 206 retail pharmacies in the GCC states, 10 multi-specialty hospitals and 7 clinics in India, and 1 clinic in the Philippines as of September 30, 2017.

Business area of the company

The company operates in multiple segments of the healthcare industry, including hospitals, clinics and retail pharmacies and provide healthcare services to patients across economic segments in several GCC states through its various brands “Aster”, “Medcare” and “Access”. A majority of its hospitals and clinics provide secondary and tertiary healthcare services to patients. In addition to providing core medical, surgical and emergency services, some of its hospitals provide complex and advanced quaternary healthcare in various specialties, including cardiology, oncology, radiology, ophthalmology, neurosciences, paediatrics, gastroenterology, orthopaedics and critical care services.

Awards and achievements

2001: MIMS Hospital, Kozhikode, India received the first place (certificate of merit) from the Kerala State Pollution Control Board for making a substantial and sustained effort in pollution control. MIMS subsequently received this certificate of merit in 2007, 2008, 2009, 2010, 2011, 2012 and 2013 for various hospitals.
2006: MIMS Hospital, Kozhikode, India received NABH accreditation valid upto October 29, 2009 which was subsequently renewed up to October 29, 2018.
2012: MIMS Laboratory Services, MIMS received ISO 15189:2007 certification in the field of Medical Testing valid up to October 8, 2016, which was subsequently renewed as ISO 15189:2012 up to October 8, 2018.
2013: Medcare Hospital LLC, Dubai, UAE received JCI accreditation valid up to December 21, 2016, which was subsequently renewed up to November 10, 2019.
2014: Aster Pharmacy Group received the Best Service Performance Brand Award by Dubai Service Excellence Scheme.
2015: Aster Medcity, Kochi, India received NABH accreditation for compliance with the Certification Standards for Nursing Excellence valid up to March 30, 2017 which was subsequently renewed up to March 30, 2019.
2015: Aster Medcity, Kochi, India received the ISO 22000:2005 certification for production and service of food for patients, staff and patients’ relatives within the hospital from Bureau Veritas Certification Holding SAS – UK Branch, valid up to July 16, 2018.
2015: The company received the ‘National Awards for Excellence in Healthcare Award for Best Marketing Campaign – Healthcare Industry’ by CMO Asia.
2016: The company received the ‘Institutional Bravery Award’ for Distinguished Service in Flood Relief in Chennai and Cuddalore, 2015 by the Society for Emergency Medicine India.
2016: Aster Pharmacies Group received the Dubai Quality Appreciation Award for 2016 from the Government of Dubai.
2016: Aster Pharmacy received the Best Service Performance Brand Award by Dubai Service Excellence Scheme.
2017: Aster CMI hospital received the ‘Best Hospitality in Healthcare’ award from the Times Network.
2017: Aster CMI hospital has been ranked as the 23rd best multi specialty hospital (national rankings), 7th best multi specialty hospital (South India) and 2nd best multi specialty hospital in Bangalore in the All India Multispecialty Hospital Ranking Survey 2017 by the Times Group.
2017: Aster CMI hospital has been ranked 11th in gastroenterology and hepatology (South India) and 3rd in gastroenterology and hepatology in Bangalore in the All India Critical Care Hospital Ranking Survey 2017 by the Times Group.
2017: Aster CMI hospital has received the ‘CMO Asia Presents Asia Healthcare Excellence Award’ in the ‘best hospitality in healthcare’ category.
2018: Aster DM Healthcare wins Special Recognition at Arabia CSR Awards 2018.
2018: Aster Pharmacy & Aster Hospital win Dubai Business Excellence Awards.
2019: Aster DM Healthcare wins four Dubai Business Excellence Awards.
2019: Aster Volunteers CSR Award PR.
2019: Aster DM Healthcare bags Gulf Business Awards-2017 for the 'Healthcare Company of the Year' Category.
2020: Aster MIMS Kottakkal conferred Six Sigma Healthcare Excellence Award.
2020: Aster DM Healthcare wins 6 awards at AHPI Awards 2020

Major Events

1987: The company’s Promoter, Dr. Azad Moopen started a clinic in Dubai.
1995: First specialty medical centre was launched in Dubai.
2001: MIMS Kozhikode Hospital commenced operations.
2005: Al Rafa Hospital for Maternity and Surgery (now called Aster Day Surgery Centre LLC) commenced operations.
2006: Medcare Hospital, commenced operations.
2008: The company acquired majority stake in PHL, Kolhapur.
2009: Al Raffah Hospital, first hospital in Oman, commenced operations in Muscat.
2010: The company acquired 100% of the paid up equity share capital of Affinity, Mauritius.
2010: Al Raffah Hospital, second hospital in Oman, commenced operations in Sohar.
2011: Second Medcare Hospital, namely Medcare Orthopedics and Spine Hospital (Dubai) commenced operations.
2013: The company acquired 60.35% of the paid up equity share capital of IHPL and consequently MIMS became its Subsidiary.
2014: The company acquired hospital operational and management rights in Aster CMC, Bangalore pursuant to the hospital operation and management agreement dated May 12, 2014.
2014: The company acquired 54% stake in Aster Kuwait and 51% stake in Orange Pharmacies LLC, Jordan.
2015: First clinic in the Kingdom of Bahrain commenced operations; first clinic in the Philippines commenced operations.
2016: The company divested its stake in Medipoint Hospitals Private Limited, Pune.
2016: The company acquired 51% stake in Dr Ramesh Hospital.
2016: Second clinic in Bahrain commences operations.
2016: Medcare Women and Child Hospital in Dubai was launched.
2017: Entered into an operation and management agreement with the Rashtreeya Sikshana Samithi Trust to operate and manage a hospital in Bengaluru.
2017: Medare Hospital Sharjah and Aster Hospital Doha commenced operations.
2018: Aster DM Healthcare partners with Nigerian University Hospital to provide advanced healthcare solutions.
2018: Aster Pharmacy launches its First Eco-Friendly Pharmacy in UAE.
2018: Sharjah Health Authority signs MoU with Aster DM Healthcare to expand healthcare coverage for residents.
2019: Aster DM Healthcare hikes shareholding in Prerana Hospital to 86.99%.
2019: Aster DM Healthcare hikes stake in Sri Sainatha Multispeciality Hospital.
2020: Aster DM Healthcare collaborates with Social Alpha.